Mirae Asset Global Investments Co. Ltd. Makes New $134.51 Million Investment in Astera Labs, Inc. $ALAB

Mirae Asset Global Investments Co. Ltd. acquired a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 377,875 shares of the company’s stock, valued at approximately $134,512,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Keating Financial Advisory Services Inc. bought a new position in Astera Labs in the 2nd quarter worth about $25,000. Archer Investment Corp purchased a new stake in shares of Astera Labs in the 2nd quarter valued at about $30,000. Transamerica Financial Advisors LLC purchased a new stake in shares of Astera Labs in the 2nd quarter valued at about $35,000. Continuum Advisory LLC purchased a new stake in shares of Astera Labs in the 2nd quarter valued at about $37,000. Finally, GK Wealth Management LLC bought a new stake in shares of Astera Labs during the 3rd quarter valued at about $29,000. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Astera Labs

In related news, Director Stefan Dyckerhoff sold 8,994 shares of the business’s stock in a transaction that occurred on Wednesday, September 2nd. The stock was sold at an average price of $274.96, for a total value of $2,472,990.24. Following the completion of the sale, the director owned 3,309 shares in the company, valued at $909,842.64. The trade was a 73.10% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the sale, the chief executive officer directly owned 1,266,665 shares of the company’s stock, valued at approximately $431,109,432.75. This represents a 6.68% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 408,558 shares of company stock worth $127,306,034 in the last quarter. 10.40% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on ALAB shares. Citigroup lowered Astera Labs from a “buy” rating to a “hold” rating in a report on Friday, October 9th. TD Cowen lowered their target price on shares of Astera Labs from $375.00 to $300.00 and set a “hold” rating on the stock in a research note on Monday, October 19th. Barclays lifted their target price on shares of Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a research report on Monday, July 20th. Zacks Research cut shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 5th. Finally, Jefferies Financial Group boosted their price target on shares of Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a research note on Wednesday, August 5th. Eleven research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $340.79.

Astera Labs Stock Down 10.9%

NASDAQ ALAB opened at $258.70 on Friday. The stock’s 50-day simple moving average is $308.12 and its two-hundred day simple moving average is $254.98. Astera Labs, Inc. has a twelve month low of $97.89 and a twelve month high of $499.48. The company has a market capitalization of $44.88 billion, a price-to-earnings ratio of 128.07 and a beta of 3.68.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The firm had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%. The company’s revenue for the quarter was up 104.5% compared to the same quarter last year. During the same period in the prior year, the business earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities analysts expect that Astera Labs, Inc. will post 2.71 earnings per share for the current fiscal year.

Astera Labs Company Profile

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.